Title: "Medication Use Among Pregnant Women With SARS-CoV-2 Infection and Risk of Hospitalization: A Study in Two Brazilian Hospitals."
Abstract: This study aimed to shed light on medication use patterns and risk factors for hospitalization due to COVID-19 in pregnant women. Conducted in two Brazilian hospitals, the research analyzed data from 278 SARS-CoV-2-positive pregnant women between March 2020 and August 2022.
Key Findings:
- 14.7% of pregnant women required hospitalization due to COVID-19, while 85.3% had mild symptoms or were asymptomatic.
- Analgesics, antibacterials, and corticosteroids were the most commonly used medications across all trimesters.
- Pre- or gestational hypertensive disorder was associated with almost a five-fold increased risk of hospitalization due to COVID-19.
- Remarkably, having at least one dose of the SARS-CoV-2 vaccine was linked to a significantly reduced risk of hospitalization.
This study provides valuable insights into medication use and risk factors for pregnant women with SARS-CoV-2 infection. It has significant implications for healthcare professionals and policymakers when managing COVID-19 in pregnancy.
We offer our sincere congratulations to the first author, Ricardo Rohweder! Ricardo is a PhD student at Universidade Federal do Rio Grande do Sul, representing one of our iAPOGEE partner institutions in Brazil. His visit was made possible by the iAPOGEE consortium.
For more details, access the full publication here: Medication Use Among Pregnant Women With SARS-CoV-2 Infection and Risk of Hospitalization-A Study in Two Brazilian Hospitals (researchgate.net)